NCT00205283View on ClinicalTrials.gov

Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection

NACompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

August 1, 2005

Study Completion Date

August 1, 2005

Conditions

HIV Infections

Interventions

DRUG

Nelfinavir

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

Sponsors

Collaborators (1)

Agouron Pharmaceuticals

All Listed Sponsors

collaborator

Agouron Pharmaceuticals

INDUSTRY

lead

University of Wisconsin, Madison

OTHER

NCT00205283 - Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection | Biotech Hunter | Biotech Hunter